EXPERIMENTAL IN VITRO PHENOTYPE REPROGRAMMING OF TWO SUBSETS OF NEUTROPHILIC GRANULOCYTES IN CHILDREN WITH ACUTE DESTRUCTIVE PNEUMONIA BY MEANS OF A SYNTHETIC HEXAPEPTIDE. The aim of the study was to evaluate the modulating effects of synthetic hexapeptide (Arginyl

CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE IMMUNOMODULATING HEXAPEPTIDE ARGINYL-ALPHAASPARTYL-LYSYL-VALYL-TYROSYL-ARGININE IN THE COMPLEX POSTOPERATIVE TREATMENT OF CHILDREN WITH ACUTE OSTEOMYELITIS of this disorder. Our objective was to evaluate the clinical and immunological efficacy of hexapeptide (HP

HLDF-6 hexapeptide neuroprotective effect on rat hippocampal neurons at the Alzheimer's disease model in vivo and in vitroHLDF-6 hexapeptide neuroprotective effect on rat hippocampal neurons at the Alzheimer's disease

HLDF-6 hexapeptide is perspective remedy in Alzheimer's disease treatmentHLDF-6 hexapeptide is perspective remedy in Alzheimer's disease treatment

MODULATING EFFECTS OF HEXAPEPTIDE ON THE ALTERED PHENOTYPE OF NEUTROPHIL GRANULOCYTE CD16+CD62L+CD11b+CD63- AND CD16+CD62L+CD11b+CD63+ SUBSETS IN CHILDREN WITH ACUTE OSTEOMYELITIS IN THE IN VITRO SYSTEM the effect of hexapeptide arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine on the altered phenotype

EFFICIENCY OF COMBINED POSTOPERATIVE TREATMENT INCLUDING AN IMMUNOMODULATORY HEXAPEPTIDE IN CHILDREN WITH ACUTE DESTRUCTIVE PNEUMONIA efficiency of immunomodulatory therapy using a medical drug with hexapeptide as an active substance

CLINICAL AND IMMUNOLOGICAL EFFICACY OF IMMUNOMODULATING HEXAPEPTIDE ASSOCIATED WITH THE RESTORATION OF CD11b+CD64-CD32+CD16+ AND CD11b+CD64+CD32+CD16+ NEUTROPHIL GRANULOCYTES SUBSET IN WOMEN WITH CHRONIC INFECTIOUS AND INFLAMMATORY DISEASES OF THE PELVIC ORGANS the effect of an original hexapeptide (HP) on negatively altered subpopulations of neutrophil granulocytes

EVALUATION OF THE EFFECTS IN THE IN VITRO SYSTEM OF SYNTHETIC THYMIC HEXAPEPTIDE ON THE EXPRESSION LEVELS OF NF-κB, IFNα/βR AND CD119 NEUTROPHILIC GRANULOCYTES IN PATIENTS WITH CHRONIC HERPES VIRAL CO-INFECTIONS; [ОЦЕНКА ВЛИЯНИЯ СИНТЕТИЧЕСКОГО ТИМИЧЕСКОГО ГЕКСАПЕПТИДА В СИСТЕМЕ IN VITRO НА УРОВНИ ЭКСПРЕССИИ NF-κB, IFNα/βR И CD119 НЕЙТРОФИЛЬНЫХ ГРАНУЛОЦИТОВ У ПАЦИЕНТОВ С ХРОНИЧЕСКИМИ ГЕРПЕСВИРУСНЫМИ КОИНФЕКЦИЯМИ]-alpha-aspartyl-lysyl-valyl-tyrosylarginine - hexapeptide (HP), a synthetic analogue of the active center of the thymopoietin (active substance of drug

Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of Alzheimer's diseaseThe neuroprotective effect of Thr-Gly-Glu-Asn-His-Arg hexapeptide (HLDF-6), a biologically active

EFFECTIVENESS OF IMMUNOMODULATORY THERAPY WITH A SYNTHETIC ANALOGUE OF THE ACTIVE CENTER OF THYMOPOIETIN IN THE COMPLEX TREATMENT OF IMMUNOCOMPROMISED WOMEN WITH CHRONIC INFECTIOUS AND INFLAMMATORY DISEASES OF THE PELVIC ORGANS with addition of an immunotherapeutic drug based on hexapeptide (HP) at a daily dose of 45 mg/ml intramuscularly